MarcusKeepMDFAANS, FACS, FRCSC

Neurosurgical Spine Surgery, Neurotrauma, Stereotactic & Functional Neurosurgery

Physician

Dr. Keep is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
700 1st Ave S
Fargo, ND 58103
Phone+1 701-234-4036

Fax+1 701-234-7830

Dr. Marcus Keep is a neurosurgeon in Fargo, ND. He received his medical degree from Medical University of South Carolina College of Medicine and has been in practice 28 years. He also speaks multiple languages, including French and Spanish. He specializes in neurosurgical spine surgery, neurotrauma, and stereotactic & functional neurosurgery and is experienced in spine traumatology.

Section of Restorative Neurology, Lund University. Olle Lindvall, M.D., Ph.D., Lund, Sweden.Fellowship, 1994 - 1996
Montreal Neurological Institute, McGill UniversityResidency, 1989 - 1994
INSERM Unité 106 (Institut National de la Santé et de la Recherche Médicale), Laboratoire de Neuromorphologie. Constantino Sotelo, M.D., Ph.D. Hopital de la Salpetriere, Paris, France.Fellowship, 1989 - 1990
Medical University of South CarolinaInternship, Surgery, 1988 - 1989
Medical University of South CarolinaClass of 1988

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
Fellow (FAANS) American Association of Neurological Surgeons

PubMed

Journal Articles

Minimally Invasive Subacute to Chronic Subdural Hematoma Evacuation with Angled Matchstick Drill and Repurposed Antibiotic Ventriculostomy Catheter Augmented with Alte...
James Dorosh , Marcus F. Keep, Cureus, 11/1/2019
Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival.
Munksgaard Thorén M, Chmielarska Masoumi K, Krona C, Huang X, Kundu S, Schmidt L, Forsberg-Nilsson K, Floyd Keep M, Englund E, Nelander S, Holmqvist B, Lundgren-Åkerlu..., Cancers, 4/25/2019

Acting Chief Medical Officer, Mitochon Pharmaceuticals, Inc.Mitochon Pharmaceuticals is a private PA pharma developing treatments for severe neurological diseases, using a remarkable class of mitochondria-trophic drugs that reduce the mitochondria proton-gradient, thereby inducing BDNF, cAMP and preventing the formation of ROS. Huntington, MS and Parkinsons.Disclosure: I am acting Chief Medical Officer, and equity holder.2018 - Present
CEO, Maas Biolab, LLCMaas Biolab is developing a treatment for amyotrophic lateral sclerosis. Maas has FDA Orphan Drug Designation for Mitogard (r) cyclosporin to treat ALS.Disclosure: I am officer, board member, patentee and equity holder.1997 - Present
Member of the Board, NeuroVive Phamaceutical, ABNeuroVive Pharmaceutical is a biopharmaceutical company in Lund, Sweden developing NeuroSTAT(r) intravenous cyclosporin for traumatic brain injury, drugs for mitochondrial disorders, and hepatic diseases, including hepatitis B and C, and hepatocellular carcinoma.Disclosure: I was a founding member of the Board 2000- 2018. I am a shareholder.2000 - 2018